: Organizations like SIGN are also updating their recommendations to emphasize that opioids should not be routinely prescribed for chronic pain due to insufficient evidence of long-term benefit [27, 35]. Managing Life with Chronic Pain
In late April 2026, the word "chronic" has dominated two very different headlines: the medical evaluations of top NFL prospects and a pivotal shift in how the FDA approaches long-term pain management. 1. The NFL Draft: The "Chronic" Red Dot Chronic
: Experts at Dr. Vince Clinical Research note that the 2025 draft guidance introduces a flexible, mechanism-based framework. This allows drug developers to target shared pain pathways across multiple conditions rather than conducting duplicative trials for every specific ailment [2]. : Organizations like SIGN are also updating their
This is for informational purposes only. For medical advice or diagnosis, consult a professional. AI responses may include mistakes. Learn more The NFL Draft: The "Chronic" Red Dot : Experts at Dr
: Use heat/cold therapy and pacing to manage daily activity [25, 36].
: In January 2025, the FDA approved Journavx (Suzetrigine) , the first non-opioid analgesic for moderate to severe acute pain, signaling a major step toward these new standards [33, 34].
: The American Society of Anesthesiologists (ASA) reinforces the use of technique-based relief, such as fascial plane blocks, to reduce opioid needs after surgery [32].